UVA1 constitutes around 75% of the terrestrial UV radiation, and most of the output of artificial tanning sources. However, the molecular effects of UVA1 in human skin in vivo are surprisingly poorly understood. We have examined time-dependent whole-genome expression, along with mRNA and protein changes in the skin after one minimal erythema dose of spectrally pure UVA1 (50 J cm À 2 ) and 300 nm UVB (30 mJ cm À 2 ). After 24 hours, the genes induced to the greatest extent were those involved in extracellular matrix remodeling with both UVA1 (P ¼ 5.5e À 7) and UVB (P ¼ 2.9e À 22). UVA1 and UVB caused different effects on matrix metalloproteinase (MMP) expression: UVB induced MMP1, MMP3, and MMP10 mRNA at 24 hours to a much greater extent than UVA1. MMP12 induction by UVA1 at 6 hours is marked and much greater than that by UVB. We have found that MMP12 mRNA induction by UVA1 resulted in expression of MMP12 protein, which is functional as an elastase. This induction of elastase activity did not occur with UVB. We hypothesize that the UVA1 induction of MMP12 mediates some of its photoaging effects, particularly by contributing to elastin degeneration in late solar elastosis. MMP12 is a good marker of UVA1 exposure.
INTRODUCTION
Terrestrial solar UV radiation (UVR) comprises o5% UVB (B295-315 nm) and 495% UVA (315-400 nm), the majority (B75%) of which is UVA1 (340-400 nm). UVA1 also makes up most (B80%) of the spectral output of sunbeds and is used at high doses as a specialist form of phototherapy (Kerr et al., 2012) . However, the acute effects of UVA1 in vivo, including its effects on gene expression, are much less well understood than those of UVB (Enk et al., 2004; Enk et al., 2006) . As it is now clear that UVA1 is biologically active and mutagenic in human skin in vivo (Mouret et al., 2006; , it is clinically important to understand the biological effects of UVA1 in the skin. Previous studies on the effects of UVA1 on wholegenome expression in vivo have been limited and have primarily focused on understanding mechanisms of pigmentation (Choi et al., 2010) .
The hallmarks of long-term exposure to solar UVR are photoaging (Yaar and Gilchrest, 2007) and photocarcino-genesis (Sage et al., 1996) . Photoaging is characterized by the induction of extracellular matrix-degrading proteolytic enzymes (matrix metalloproteinases, MMPs) without a parallel induction of inhibitors of proteolysis (tissue inhibitor of metalloproteinases). The resulting pathological remodeling process involves the degradation of collagen and the accumulation of abnormal elastin in the superficial dermis, resulting in the characteristic changes of solar elastosis (Chen et al., 1986; Uitto, 2008) . Previous studies with UVR sources rich in UVB showed induction of MMP1, MMP3, and MMP9 mRNA (Brenneisen et al., 1996; Fisher et al., 1996; Fisher et al., 1997) in human skin in vivo. UVA sources have also been reported to induce MMP1 expression in fibroblasts (Scharffetter et al., 1991; Herrmann et al., 1993) . There are few data on the effects of spectrally pure UVA1 on MMPs in human skin in vivo (Wang et al., 2013) .
MMP activity is required both in normal physiological processes such as wound healing and angiogenesis (Chakraborti et al., 2003) and in the pathological tissue destruction that occurs in chronic wounds, dermal photoaging, bullous skin disease, cancer invasion, and metastasis (Kerkela and Saarialho-Kere, 2003) . The mechanisms by which UVR induces MMPs are poorly understood. Some studies have reported that this occurs via the generation of reactive oxygen species (Scharffetter-Kochanek et al., 1993; Fisher et al., 2009) , whereas others have suggested that DNA is a major chromophore and that MMPs are triggered by the formation of cyclobutane pyrimidine dimers (CPDs) (Dong et al., 2008) . MMPs may also be induced by mediators such as tumor necrosis factor a (Steenport et al., 2009) , which is also readily induced in the skin by UVR, probably via the induction of CPDs (Walker and Young, 2007) and IL6 (Wlaschek et al., 1994) .
It is widely considered that UVA has a larger role than UVB in photoaging, both because of the deeper penetration of UVA into the dermis (Bruls et al., 1984) and because of the sensitivity of fibroblasts to UVA-induced MMPs (Scharffetter et al., 1991; Herrmann et al., 1993) . There are inherent problems with previous studies that relate to spectral purity of the source of UVR. UVB sources often also emit a considerable amount of UVA and it is not possible to attribute an effect to UVB without knowledge of the action spectrum of the end point under investigation. Even minor contamination of a nominal UVA source with very small amounts of UVB may give misleading results because o1% UVB contamination can be responsible for most of a given effect, e.g., DNA damage (Woollons et al., 1999) . Also, UVA2 (315-340 nm) and UVA1 are biologically and mechanistically different. Thus, we have concentrated our studies on the biological effects of spectrally pure UVB (300 nm) and UVA1. In a recent work, we reported that solar UVB exposure was probably the most important factor in MMP1 induction from an environmentally relevant perspective . In this study, we compare the effects in vivo of erythemally equivalent and biologically relevant doses of spectrally pure UVA1 and UVB on whole genome expression, mRNA, and protein and enzyme activity of the most significantly enriched pathway at 24 hours (extracellular matrix remodeling). We have used this approach because erythema is the widely used end point in clinical and experimental photodermatology. We chose 300 nm because it is in the region of the peaks of the action spectra both for erythema and for CPD induction in human skin in vivo (Young et al., 1998) and its photobiological effects are likely to be mechanistically different from UVA1. Furthermore, erythemal exposure, quantified by the standard erythema dose, is increasingly used as a measure of UVR exposure in clinical and epidemiological studies.
RESULTS
Extracellular matrix remodeling genes are induced to a greater extent than other pathways, both by UVA1 and by UVB 24 hours after exposure.
We used Genego Metacore v7 on our microarray data to identify upregulated pathways at 6 and 24 hours using the pooled intensities (n ¼ 9 for UVA1 and n ¼ 5 for UVB) of upregulated genes compared with each individual's nonirradiated control (Po0.05, fold change X2). At 6 hours, the most significantly enriched pathway was inflammation through Th17 signaling for erythemally equivalent doses of UVA1 (P ¼ 1.16e À 6) and UVB (P ¼ 2.1e À 4). At 24 hours, the most significantly enriched pathway was extracellular matrix remodeling for UVA1 (P ¼ 5.5e À 7) and UVB (P ¼ 2.9e À 22). Many other groups of genes were induced to lesser extents but this paper will focus on the MMPs, given their striking degree of induction.
Whole-skin microarray analysis at 6 ( Figure 1a ) and 24 hours (Figure 1b) after exposure indicated that genes encoding MMP1, MMP3, MMP9, MMP10, and MMP12 are induced predominantly at 24 hours. MMP1, MMP3, and MMP10 (10-550-fold, Pp0.05, adjusted Pp0.3) were induced to a greater extent by UVB, whereas UVA1 induced a 15-fold increase in MMP12 gene expression at 6 hours (Pp0.05, adjusted Pp0.3) that increased to around 30-fold at 24 hours (Pp0.05, adjusted Pp0.3).
Key UVA1 and UVB mRNA expression differences
Specific genes assessed by reverse transcription quantitative PCR (qPCR) at 6 and 24 hours are shown in Figure 1c -h. At 24 hours, UVB was more effective than UVA1 at inducing MMP1 (P ¼ 0.0062, UVB/UVA1 fold difference 13.2) ( Figure 1c ), MMP3 (P ¼ 0.0016, UVB/UVA1 fold difference 38.7) ( Figure 1d ), and MMP10 (P ¼ 0.028, UVB/UVA1 fold difference 27.1) ( Figure 1e ). Both UVA1 and UVB induce MMP9 mRNA to an equal extent (at 6 and 24 hours post exposure ( Figure 1f ); P ¼ 0.33 at 6 hours, P ¼ 0.12 at 24 hours). UVA1 was more effective than UVB at inducing MMP12 mRNA at 6 (P ¼ 0.02, UVA1/UVB fold difference 19.2) and 24 hours (P ¼ 0.22, UVA1/UVB fold difference 8.26). However, the large interindividual variation at 24 hours means that the difference is not significant (Figure 1g ). UVA1 did not induce MMP3 or MMP10.
UVR-induced MMP1 protein and its activity in the epidermis
Typical MMP1 and MMP12 protein staining (red fluorescence) and enzyme activity (in situ zymography shown by green fluorescence) are shown in Figure 2a and b, respectively. UVB and UVA1 induce MMP1 protein (at 10 and 24 hours (Figure 2c) ) to a similar extent. Enzyme activity is preferentially induced by UVB at 24 hours compared with UVA1 (P ¼ 0.031) ( Figure 2d ). DQ collagen type I is a substrate for MMP1, MMP2, MMP3, MMP9, and MMP13 (Yan and Blomme, 2003) . Figure 3a shows that MMP2 protein was not induced by either spectrum at 24 hours. However, as shown in Figure 3b , UVB induced an increase in MMP9 protein at 24 hours.
UVA1 preferentially induces MMP12
MMP12 protein is predominantly formed by UVA1 at 24 hours (P ¼ 0.04) (Figure 2e ). A lesser degree of induction of MMP12 protein is seen with UVB at 10 and 24 hours, despite the absence of MMP12 mRNA induction by UVB at 6 and 24 hours. There is significantly (P ¼ 0.027) more MMP12 activity at 10 hours after UVA1 exposure than after UVB (Figure 2f ). that UVA1, but not UVB, induces elastin breakdown in the epidermal region.
Location of MMP1 and MMP12 proteins within the epidermis
Macrophages are a potential source of UVA1-induced MMP12 Figure 5b shows significant depletion of dermal macrophages (CD68 þ ) 24 hours after UVB exposure. In contrast, UVA1 had no effect on dermal macrophage numbers (P ¼ 0.21) compared with nonirradiated controls.
DISCUSSION
We have compared UVR-induced MMPs using spectrally pure UVB (300 nm) and UVA1 on the same individuals, which is likely to reduce the impact of interpersonal variation. Our UVA1 doses are physiologically relevant; 50 J cm À 2 would be a typical dose received from a 2.5 hour exposure to the tropical Australian sun (19 1S) (Bernhard et al., 1997) and higher doses are regularly given for treatment of sclerosing skin conditions (Kerr et al., 2012) .
Baseline expression of MMPs is usually low in human tissue, including skin. Our gene array data (supported by qPCR) show that erythemally equivalent doses of UVB and UVA1 induce many MMPs. There was no increase in tissue inhibitor of metalloproteinases 1-4 with either spectrum assessed by microarray (data not shown). For most MMPs, induction by UVB peaked at 24 hours, although some expression is seen at 6 hours with some MMPs. MMP12 gene and mRNA expression by UVA1 is seen at 6 hours but primarily at 24 hours. The most striking fold increases with UVB were for MMP1 and MMP3 with array and qPCR technology. There was also an impressive increase of MMP10 mRNA with qPCR. Neither UVB nor UVA1 had any effect on MMP2 assessed by microarray, mRNA (data not shown), and protein. The most striking effect of UVA1 was on MMP12, as assessed by the three techniques. In contrast, UVB had little effect on MMP12 expression. There was modest or no evidence of any UVA1 induction of MMP3 or MMP10 by qPCR. MMP12 mRNA expression has been reported in human skin in vivo at 16 and 24 hours by others (Chung et al., 2002) , after a 2 minimal erythema dose (MED) exposure from a broad-spectrum UVB-UVA source. In another study, no MMP12 mRNA was detected after exposure to UVA1 or broad-spectrum UVR (UVB with UVA) for three consecutive days (Saarialho-Kere et al., 1999) .
Recently, it was shown that 40 J cm À 2 UVA1 in human skin in vivo increased MMP1 and MMP3 mRNA by B80and 50fold, respectively, at 24 hours (Wang et al., 2013) . These data are comparable to the responses we see to 50 J cm À 2 UVA1 (especially for MMP3), which are 25-and 45-fold compared to nonirradiated control tissue for MMP1 and MMP3, respectively (see Figure 1c and d), given the error range in both data sets. Repeated (4 Â ) low-dose UVA1 on human skin in vivo results in an accumulation of MMP1 and MMP3 mRNA expression (Wang et al, 2013) .
Our protein studies show that UVR-induced MMPs are predominantly expressed in the epidermis, which is expected because of their role in epithelial tissue homeostasis after UVR injury. Other studies support this observation (MMP1, MMP3, and MMP9 mRNA and MMP1 activity) after exposure to solar-simulating radiation ). However, we believe that our data demonstrate MMP1 protein/activity by spectrally pure UVB and UVA1.
There are eight elastases in human skin (Liang et al., 2006) , of which human macrophage elastase (HME) or MMP12 (Shapiro, 1998; Shapiro et al., 1993) , and neutrophil-derived (neutrophil elastase (NE)) are induced by UVR (Lee et al., 2008) . NE has long-term photobiological significance, because NE-deficient mice are resistant to photoaging (Starcher and Conrad, 1995; Takeuchi et al., 2010) and squamous cell carcinoma formation (Starcher et al., 1996) after exposure to a source containing 10% UVB and 90% UVA. This suggests that elastase may be linked to these two long-term consequences of UVR exposure.
MMP12 protein has been detected in ''a few stromal fibroblast/macrophage-like cells'' after exposure to UVA1 (Saarialho-Kere et al., 1999) . A modest induction of dermal fibroblast MMP12 (but not in macrophages) has also been reported in human skin in vivo after a 2 MED exposure from a broad-spectrum UVB-UVA source (Chung et al., 2002; Saarialho-Kere et al., 1999) . UVB induced significantly greater (P ¼ 0.02) depletion of papillary dermal macrophages than did UVA1 (Figure 5b ). Thus MMP12 could be explained by the larger presence of activated macrophages in the dermis after UVA1. MMP12-negative macrophages cannot penetrate the dermal/epidermal junction (Shipley et al., 1996) , and we found no evidence of epidermal macrophages. We did not stain for NE, but dermal neutrophil infiltration (and likely NE release) is a predominantly UVB-driven process (Lee et al., 2008) and is therefore unlikely to explain our UVA1 data. MMP12 is also produced by activated T cells (Hughes et al., 1998) , transformed keratinocytes, and keratinocyte-derived tumors (Kerkela et al., 2000) . Given that we found MMP12 primarily in the epidermis, irrespective of spectrum, we suggest that it is mainly derived from normal keratinocytes. However, we cannot exclude the possibility that some MMP12 may be derived from dermal cells such as fibroblasts and macrophages.
UVB and UVA1 induced the degradation of DQ collagen type I. The assessment of specific MMP function by in situ zymography is complicated by cross-reactivity. DQ collagen type I is primarily a substrate for MMP1 but is also degraded by MMP2, MMP3, MMP9, and MMP13 (Yan and Blomme, 2003) . There is no UVR induction of MMP2 mRNA or protein (Figure 3a ) at 24 hours but there is a small (B20%) significant increase in MMP9 protein by UVB (Figure 3b ). This has been previously reported (as 92 kd gelatinase) (Fisher et al., 1997) with a broad-spectrum UVB-UVA source. As UVB and UVA1 induce MMP13 mRNA to similar extents (Figure 1h) , it is possible that the UVB-induced collagen I hydrolytic activity is also mediated via MMP3 and MMP9. We did not measure MMP3 protein, but UVB resulted in a very large increase in its mRNA that was not seen with UVA1. However, MMP3 protein (stromelysin-1) has been shown to increase after exposure to a UVB-UVA source (Fisher et al., 1997) .
UVA1 was more effective than UVB for the degradation of DQ collagen type IV in the epidermis (10 hours). This is primarily a substrate for MMP12, but it is also hydrolyzed by MMP2, MMP7, MMP9, and MMP25 (Yan and Blomme, 2003) . As MMP2, MMP7, MMP9, and MMP25 mRNAs were not induced by UVA1, the induction of enzyme activity is more likely to reflect the induction of MMP12. This is also supported by the lack of UVA1 effects on MMP2 and MMP9 protein expression. There is some collagen IV hydrolysis with UVB at 10 and 24 hours that could be due to UVB-induced MMP9 (Figure 3b ), although without MMP12-blocking enzymes we cannot rule out the effects of MMP12.
UVB was significantly more effective than UVA1 at inducing epidermal MMP1 activity at 24 hours. In contrast, UVA1 was more potent at induction of epidermal MMP12 protein (24 hours) and its activity (10 hours) against DQ collagen type IV. It was also significantly better at the induction of dermal MMP1 and MMP12 proteins at 24 hours. This difference is likely to be due to greater UVA1 dermal penetration/scattering (Tewari et al., 2011; . Interestingly, we found no spectral differences for dermal MMP1 and MMP12 activity against their respective collagen substrates, but there was large interpersonal variation. There was some UVB-induced MMP12 protein, predominantly in the epidermis, but to a much lesser extent than with UVA1. The small amount (relative to epidermis) of UVA1-induced MMP12 in the dermis, maybe insufficient to degrade elastin at 24 hours because no elastase activity was detected in the dermal region, although this was considerable in the epidermal region. This may be attributed to greater MMP12 protein induction in the epidermis. This is also supported by the in situ zymography data for degradation of collagen IV. Essentially, the degradation of two substrates by MMP12 was an epidermal phenomenon in which UVA1 was more effective than UVB.
Dermal extracellular collagens are degraded in photoaging. Quan et al (2009) have suggested that epidermal MMP1, MMP3, and MMP9 (where they report the majority is synthesized), diffuse into the dermis to degrade collagen ). However, studies on photoaged skin show more MMPs in the dermis than in the epidermis (Chung et al., 2002; Quan et al., 2013) . Overall, this suggests that repeated solar UVR exposure results in an accumulation of dermal MMP, whether by diffusion from the epidermis or by a gradual accumulation of dermally synthesized protein. It is also possible that our 24-hour sampling time was not optimal for MMP12 diffusion from the epidermis into the dermis and the degradation of elastin.
Light microscopy shows that the papillary dermis of photoaged skin contains an accumulation of amorphous disorganized elastin fibrils, which is known as ''solar elastosis'' (Calderone and Fenske, 1995; Yaar and Gilchrest, 2007) . In its early stages, there is an accumulation of insoluble disorganized elastin and microfibrillar proteins (fibronectin) (Chen et al., 1986; Lavker and Kligman, 1988) , seen clinically as waxy, thickened, and furrowed facial skin. In more advanced solar elastosis, degeneration of dermal elastin results in a mottled appearance that is clinically associated with a loss of skin elasticity. The addition of an elastase to an elastin culture (Braverman and Fonferko, 1982) results in a mottled appearance that is similar to that seen in late solar elastosis. This appearance, termed ''zebra bodies'', can also be induced by repeated erythemal doses of UVA, but not by solarsimulated radiation (Kumakiri et al., 1977) .
Our data with gene array, qPCR, and protein activity strongly suggest that UVA1 preferentially induces MMP12. We acknowledge that our protein studies are based on small sample sizes (n ¼ 3). However, they generally correlate with the mRNA data, and the protein expression and activity data are mutually consistent. Our elastase activity data ( Figure 5 ) are particularly striking. MMP12 protein has been observed in the upper dermis of patients with solar elastosis and actinic keratosis (Saarialho-Kere et al., 1999; Chung et al., 2002) . Chung et al. (2002) suggest that MMP12 has a role in elastin remodeling in solar elastosis of the face. We suggest that solar Figure 4 . UVA1 induces more dermal metalloproteinase (MMP) protein than UVB. Using immunofluorescence and in situ zymography (a) there was more UVA1-induced MMP1 than UVB-induced MMP1 at 24 hours, (b) there were no spectral differences for the degradation of dermal DQ1, (c) there was more UVA1-induced MMP12 than UVB-induced MMP12 at 24 hours, and (d) there were no spectral differences for the degradation of dermal DQ4. Scale bar ¼ 50 mm. *Pp0.05, **Pp0.01; n ¼ 3.
elastosis, and its association with MMP12, may be explained by our studies because MMP12 is the major enzyme for the degradation of elastin (Gronski et al., 1997; Woessner, 1991) . However, we cannot exclude other MMPs having a role in the pathogenesis of solar elastosis, because MMP2, MMP7, and MMP9 also have elastolytic activity and may be induced by UVB (e.g., MMP9 as shown in Figure 3b ). In addition, MMP12 degrades other substrates apart from type IV collagen including laminin 1, fibronectin, vitronectin, and proteoglycans (Gronski et al., 1997) . We hypothesize that solar UVA1 induces the expression of MMP12, which then degrades elastin, contributing to the loss of skin elasticity seen in late solar elastosis. This may occur, as suggested by Quan et al (2009) , by diffusion of the MMPs from the epidermis to the upper dermis. The resultant loss of elasticity, termed ''sagging'', has been shown to be a UVA1-dependent process in hairless mice, with an action spectrum peak at 340 nm (Bissett et al., 1987 (Bissett et al., , 1989 . This suggests that UVA1 has important implications for photoaging and also possibly photocarcinogenesis (Starcher and Conrad, 1995; Starcher et al., 1996) . This is supported by studies that show that people habitually exposed to UVA through glass on one side of the face show more signs of photoaging and skin cancer on the exposed side (Butler and Fosko, 2010 A reduction of photoaging in an intense solar environment has been observed with the long-term discretionary use of a sunscreen (SPF 15 þ ) (Hughes et al., 2013) . Its formulation is not photostable, and would have lost most of its UVA1 protection within 1 hour (Dr B Herzog, personal communication). Our MMP12 data support the inclusion of good photostable UVA1 protection in sunscreens to enhance their ability to inhibit photoaging. Furthermore, our data suggest that the inhibition of MMP12 may be a future strategy for protecting against photoaging.
The absorption of UVR by chromophores mediates all photobiological reactions. UVB absorbed by DNA results in CPD formation, the action spectrum of which peaks at 300 nm in human skin in vivo (Young et al., 1998) . There is evidence that DNA is a chromophore for MMP1 via CPD formation (Dong et al., 2008) . Our recent findings Tewari et al., 2011) showed considerable attenuation of UVBinduced CPDs with skin (epidermis and dermis) depth, which was not the case with UVA1. Thus, we would expect to see marked attenuation of UVB-induced MMP1 with skin depth, as shown in Figures 2g and 4a , if DNA were the putative chromophore. In contrast, epidermal depth has no effect on the distribution of MMP12 induced by UVB or UVA1 (Figure 2i and j) . This suggests that they have different chromophores. We therefore propose that UVA1 induces MMP12 via a non-DNA chromophore that generates reactive oxygen species (Scharffetter-Kochanek et al., 1993; Wlaschek et al., 1995) . This is supported by studies that showed that topical reactive oxygen species scavengers reduced MMP12 mRNA in human skin (Chung et al., 2002) . UVA1 did not induce MMP3 or MMP10 when assessed by qPCR. Our erythemal dose of UVA1 (50 J cm À 2 ) does induce CPDs, although at one-fourth to one-third times lower levels than after an erythemally equivalent exposure to UVB (Tewari, Sarkany et al., 2011) . This suggests that these enzymes may not only have a CPD threshold but may also have non-DNA chromophores that are required for their induction.
MATERIALS AND METHODS

Volunteers
The studies were approved by the St Thomas' Hospital, London, UK Ethics Committee (Ref: 09/H0802/98) in accordance with the declaration of Helsinki. The details of the 12 healthy skin type I/II volunteers are shown in Table 1 . Participants gave written informed consent before taking part in the study.
Irradiation
UVR sources, dosimetry, and irradiation protocol. Emission spectra and irradiances of the UVA1 and UVB sources, and assessment of MED are previously described (Tewari et al., 2011) . Table 1 shows that the mean MEDs for 12 volunteers were 29.2±5.8 mJ cm À 2 (UVB) and 58.6±7.9 J cm À 2 (UVA1).
Experimental protocol. (i) ''UVA1 time course'': four skin type I/II volunteers were irradiated over a 1-cm 2 area on previously unexposed buttock skin with 50 J cm À 2 UVA1 and 4-mm punch biopsies were taken under local anesthesia 6 and 24 hours later. This was B1MED (minimal erythema dose) and was based on our previous work (Tewari et al., 2011) . (ii) ''UVA1 and UVB comparison'': five skin type I/II participants were exposed to 50 J cm À 2 UVA1 and 30 mJ cm À 2 (B1MED) UVB and biopsies were taken at 6 and at 24 hours. (iii) ''Protein validation'': 
Protein validation
Biopsies were placed in OCT (VWR Chemicals, Leuven, Belgium), embedded in isopentane (VWR Chemicals, Fontenay-sous-Bois, France), and once placed in cryovials were then frozen in liquid nitrogen. 5-7 mm sections were mounted on Superfrost plus slides and stored at À 80 1 C. Sections were placed at room temperature (10 minutes), fixed in cold acetone (10 minutes), then rinsed in phosphate-buffered saline (PBS) for 5 minutes. (i) Immunofluoresecence: sections were incubated with blocking buffer for 20 minutes (10% goat serum (DAKO, Cambridge, UK) 0.1% BSA, 0.1% Tween-20 in PBS), washed in PBS, incubated for 90 minutes with MMP1 (1:100), MMP12 (1:400) (recognizes the proactive and active forms of MMP12), rabbit antihuman antibodies (Abcam, UK), CD68 (1:100) mouse antihuman antibody (Abcam, Cambridge, UK) washed in PBS, and incubated with either Alexa Fluor goat antirabbit 555 or goat antimouse 555 (Invitrogen, Paisley, UK) at 1:200 for 30 minutes, counterstained with prolong gold antifade with DAPI (Molecular Probes, Paisley, UK), coverslipped, and stored away from light. Imaging was performed with a Zeiss Axiophot microscope (Harpenden, UK) and Nikon DS-U2 camera (Kingston upon Thames, UK). Images were captured in 2560 Â 1920 format, gain Â 1.00, 4 second exposure. (ii) in situ zymography: slides were incubated with 60 ml substrate (low-gelling agarose (Sigma, Dorset, UK) (1 g dissolved in 500 ml PBS)), with four drops of 4 0 ,6-diamidino-2-phenylindole with antigold fade (Invitrogen) and DQ-collagen 1, DQ-collagen 4, or DQ elastin (all from Molecular Probes) at 1:10 for B18 hours in the dark. Fluorescent imaging for fluorescein (green) and 4 0 ,6-diamidino-2phenylindole (blue) was performed. Images were obtained as above and captured in 2560Â 1920 format, gain Â 1.00, 1 second exposure. Analysis was performed using NIS elements BRv2 software package as previously described (Tewari et al., 2011) after removing background control intensity. For the spread of MMP1 and MMP12 across the epidermis, thresholding was set to capture red intensity, and upper epidermis and lower epidermis were visually gated to give mean intensity values corresponding to MMP amount.
Data analysis
For microarray data, bioinformatical analysis was based on normalized Log 2 intensities using R/Bioconductor and software packages therein (http://www.R-project.org; http://www.bioconductor.org). Analysis of variance with repeated measurements followed by Tukey post hoc tests was used to test for expression differences among the groups. The UVA1 time course was as follows: UVA1 6 hours versus UVA1 24 hours (50 J cm À 2 doses), UVA1 versus UVB at 6 hours, and UVA1 versus UVB at 24 hours. All P-values were adjusted for multiple testing (Benjamini and Hochberg, 1995) . Differentially expressed genes were considered if both the analysis of variance and Tukey post hoc test P-values were p0.05 (adjusted P-value or false discovery rate p0.3) and the expression difference was at least twofold. Functional analysis of candidate genes was performed using DAVID (Database for Annotation, Visualization and Integrated Discovery) v6.7 (Dennis et al., 2003) to identify biological clusters and GeneGo Metacore v7 to identify key pathways. Briefly, gene ratio lists for pooled individuals (fold change X2, Pp0.05) from the 6-and 24-hour biopsies were uploaded to the software program, which generated pathway maps and P-values associating the statistical likelihood of a sequence of genes with a particular pathway. All graphs were generated using the Graphpad Prism v4 statistics package.
